Skip to main content

ALTERACIONES DE LA CORTEZA INFRALIMBICA EN DEPRESION: MECANISMO DE ACCION DE NUEVAS ESTRATEGIAS ANTIDEPRESIVAS

SAF2015-68346-P

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D (Excelencia / Generación de Conocimiento)
Call year 2015
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Modulation of thalamo-cortical activity by ketamine in rats

  • Amat Foraster, María
  • Celada, Pau
  • Jensen, Anders A.
  • Plath, Niels
  • Artigas, Francesc
  • Herrik, Kjartan F.
Trabajo presentado en el Neuroscience 2017, celebrado en Washington del 11 al 15 de noviembre de 2017, Background: Faster and more effective antidepressant treatments are needed to overcome the limitations of current monoamine-based drugs. Interestingly, sub-anesthetic doses of ketamine have been shown to produce immediate and persistent antidepressant effects. However, ketamine use is limited by its psychotomimetic properties and abuse potential. Therefore, we investigated the actions of ketamine on thalamo-cortical networks to increase our knowledge of the brain circuitry affected by ketamine and thus elucidate the mechanism underlying its antidepressant effects, ultimately leading to the development of novel antidepressants without ketamine’s side effects. Methods: We conducted single unit and local field potentials recordings in the mediodorsal (MD), centromedial (CM) and reticular (RtN) nucleus of the thalamus, as well as in the medial prefrontal cortex (mPFC) of freely-moving (except RtN) and chloral hydrate anesthetized male Wistar rats, using microelectrode arrays and glass electrodes. The acute effects of ketamine (3 and 10 mg/kg s.c. in freely-moving rats; 1, 2 and 5 mg/kg i.v. in anesthetized rats) on the firing properties and oscillations of these neuronal populations were assessed. The effects of ketamine at 24 hours post administration were also examined in the freely-moving recordings. Results: In anesthetized rats, ketamine acutely decreased the discharge rate of RtN, MD/CM and layer VI mPFC neurons projecting to the thalamus. In addition, ketamine modulated oscillatory rhythms, reducing the power of low frequency oscillations in anesthetized rats and increasing gamma oscillations in both freely-moving and anesthetized rats. Moreover, increases in high frequency oscillations were observed in freely-moving rats. These effects were short-lasting since they were not present at 24h post administration. Further analysis is needed to characterize the changes observed on the firing characteristics in freely-moving rats. Conclusion: This study provides insights on the neurobiological changes that occur in the thalamo-cortical networks by ketamine both acutely and at 24 hours post administration. Ongoing efforts to characterize the firing rates of these neuronal populations in freely-moving rats will be crucial to understand the implications of the observed effects by ketamine in the thalamo-cortical networks of anesthetized rats., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Murine model of depression: astroglial glutamate transporter knockdown in infralimbic cortex induces a depressive phenotype

  • Fullana, Neus
  • Ruiz-Bronchal, Esther
  • Ferrés-Coy, Albert
  • Bortolozzi, Analía
  • Artigas, Francesc
Trabajo presentado en el Neuroscience 2017, celebrado en Washington del 11 al 15 de noviembre de 2017, Emerging evidence suggests that dysregulations of glutamatergic neurotransmission in prefrontal cortex are involved in the pathophysiology of depression. Astrocytes regulate excitatory neurotransmission by removing synaptic glutamate via GLAST and GLT-1 transporters. We demonstrated that unilateral knockdown of GLAST and GLT-1 in mouse infralimbic (IL) cortex induced by the local micro-infusion of small interfering RNAs (siRNA) targeting either transporter evoked a depressive-like phenotype. Conversely, intra-prelimbic (Prl) cortex microinfusion of both siRNAs did not affect behavioral responses despite comparable reductions of GLAST and GLT-1-1 expression in both PFC subdivisions. Downregulation of GLAST and GLT-1 remained diminished for at least 3 day and recovered 7 days post-administration. The depressive-like phenotype induced by reducing GLT-1 and GLAST expression in IL may be due to a hypoactive serotonergic (5-HT) system since it was reversed by the antidepressant drug citalopram. Likewise, microdialysis experiments revealed that siRNA-treated mice exhibited a reduced basal 5-HT release in the dorsal raphe nucleus (DRN) compared with controls, and a similar effect of veratridine in both experimental groups, indicating a similar intracellular 5-HT content. Further, local infusion of the GABAA receptor antagonist bicuculline increased DRN-5-HT release more markedly in siRNA-treated mice, suggesting a greater inhibition of 5-HT neurons via GABAA receptors. However, local downregulation of both transporters in PrL did not alter baseline 5-HT in DRN not the effect of bicuculline on 5-HT release. Taken together, these observations suggest that 1) an alteration of astroglial glutamate uptake in ventral PFC regions (IL) evokes downstream changes in 5-HT function, associated to a depressive-like phenotype in mice, and 2) the regional specificity of the effect suggests a differential functional connectivity between PrL/IL and DRN 5-HT neurons. In addition, this potential new model of MDD shows several physio pathological markers observed in patients: reduced expression of GFAP, a smaller number of astrocytes in mPFC, as well as a decreased BDNF expression in mPFC and the hippocampal formation, which is highly and significantly correlated with the degree of glutamate transporter knockdown in IL, indicating a direct relationship between both processes. Overall, these findings improve our understanding of the pathophysiology of depression and could help to identify novel targets in antidepressant drug development, since this potential new MDD model mimics many of the functional and molecular alterations observed in MDD patients., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Serotonin receptors: Implications for depression and its treatment

  • Castañé, Anna
  • Artigas, Francesc
Trabajo presentado en el 14th World Congress of Biological Psychiatry, celebrado en Vancouver (Canadá), del 2 al 6 de junio de 2019, Objective: Major depressive disorder (MDD) is a psychiatric syndrome with a high socioeconomic impact, due to its high prevalence and to the limited efficacy of treatments. Antidepressant efficacy depends, to a large extent, on the synaptic availability of serotonin (5-hydroxytryptamine; 5-HT) even for fast-acting strategies such as ketamine. However, blockade of the 5-HT transporter (SERT), as evoked by most antidepressant drugs (TCAs, SSRI, SNRI, etc.) is insufficient by itself to improve symptoms in many patients. The aim of the present talk is to describe the principal serotonergic mechanisms that facilitate or slow the antidepressant response., Support from SAF2015-68346-P is acknowledged.